Taiwan FDA registration 1551945118f656d2f5e431d5427564b0

Nofasideros, varicella zoster virus immunoglobulin A enzyme immunoassay kit

TW: 諾法鐵水痘帶狀皰疹病毒免疫球蛋白A酵素免疫分析套組

Taiwan·Risk Class 2·GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH·Registered Aug 14, 2006 – Aug 14, 2026Active

Registration details

Analysis ID: 1551945118f656d2f5e431d5427564b0
Customs Code: DHA00601727909

Company information

Manufacturer: GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH
Manufacturer Country: Germany
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: It is a qualitative detection of immunoglobulin A classification antibody against human varicella zoster virus in human serum.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3900 Varicella Disease Poison Serum Trial
Import Information: import

Dates and status

Registration Date: Aug 14, 2006
Expiry Date: Aug 14, 2026

About this record

Access comprehensive regulatory information for Nofasideros, varicella zoster virus immunoglobulin A enzyme immunoassay kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1551945118f656d2f5e431d5427564b0 and manufactured by GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.